Boston Scientific (BSX) to Acquire Bolt Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Deutsche Bank Upgrades Boston Scientific (BSX) to Buy
January 10, 2025 7:08 AM ESTDeutsche Bank analyst Pito Chickering upgraded Boston Scientific (NYSE: BSX) from Hold to Buy with a price target of $108.00 (from $87.00).
The analyst comments "So the BSX story has become simpler, and as one of the best-in-class medtech names, we believe BSX is poised again to outperform in 2025, and we are upgrading the shares to Buy with a $108 price target which is 34x our 2026E EPS. There are many risks to our Buy thesis: (1) BSX is one of the most consensus longs within our coverage universe. So who might be the... More



